KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingTax ProvisionsTax Rate
Others
Ratios

Omega Healthcare Investors (OHI) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Omega Healthcare Investors (OHI) over the last 17 years, with Q4 2025 value amounting to $169.2 million.

  • Omega Healthcare Investors' Net Income towards Common Stockholders rose 4925.84% to $169.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $609.7 million, marking a year-over-year increase of 5004.82%. This contributed to the annual value of $609.7 million for FY2025, which is 5004.82% up from last year.
  • Per Omega Healthcare Investors' latest filing, its Net Income towards Common Stockholders stood at $169.2 million for Q4 2025, which was up 4925.84% from $186.9 million recorded in Q3 2025.
  • Omega Healthcare Investors' 5-year Net Income towards Common Stockholders high stood at $189.6 million for Q1 2022, and its period low was $33.3 million during Q4 2021.
  • Its 5-year average for Net Income towards Common Stockholders is $105.1 million, with a median of $106.6 million in 2022.
  • Per our database at Business Quant, Omega Healthcare Investors' Net Income towards Common Stockholders surged by 25220.23% in 2021 and then crashed by 8104.39% in 2023.
  • Omega Healthcare Investors' Net Income towards Common Stockholders (Quarter) stood at $33.3 million in 2021, then skyrocketed by 36.91% to $45.6 million in 2022, then increased by 20.67% to $55.0 million in 2023, then soared by 106.07% to $113.3 million in 2024, then soared by 49.26% to $169.2 million in 2025.
  • Its last three reported values are $169.2 million in Q4 2025, $186.9 million for Q3 2025, and $142.7 million during Q2 2025.